Targeted Medical Pharma, Inc. (OTCMKTS:TRGM – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Targeted Medical Pharma shares last traded at $0.00, with a volume of 0 shares changing hands.
Targeted Medical Pharma Stock Performance
Targeted Medical Pharma Company Profile
Targeted Medical Pharma, Inc, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy.
Recommended Stories
- Five stocks we like better than Targeted Medical Pharma
- Buy P&G Now, Before It Sets A New All-Time High
- Should You Invest in Treasury Bills?
- Do ETFs Pay Dividends? What You Need to Know
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- Investing in the High PE Growth Stocks
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for Targeted Medical Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Targeted Medical Pharma and related companies with MarketBeat.com's FREE daily email newsletter.